R. Wendel Naumann, MD
R. Wendel Naumann, MD
Director Minimally Invasive Surgery - Gyn Onc
Levine Cancer Institute
Division of Gynecologic Oncology
309 E. Morehead St
Apt 922
Charlotte,
NC
USA
28202
Papers:
8
A randomized double-blind phase III trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD/Doxil®/Caelyx®) in combination versus PLD in participants with platinum-resistant ovarian cancer (PROCEED) (NCT01170650)